<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04859478</url>
  </required_header>
  <id_info>
    <org_study_id>H-20035522</org_study_id>
    <nct_id>NCT04859478</nct_id>
  </id_info>
  <brief_title>Venous Phase Dual Energy CT in Patients Suspected for Pulmonary Embolism.</brief_title>
  <official_title>Venous Phade Dual Energy Computed Tomography in Patients Suspected for Pulmonary Embolism: Diagnostic Accuracy and Evaluation of Incidental Findings.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Copenhagen University Hospital at Herlev</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Copenhagen University Hospital at Herlev</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Venous phase spectral or dual energy (DE) chest computed tomography (CT) in patients with&#xD;
      suspected pulmonary embolism (PE) compared to standard computed tomography pulmonary&#xD;
      angiography (CTPA): sensitivity, evaluation of iodine mapping and incidental findings.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background/rationale: DE CTPA provides additional anatomical and functional information in&#xD;
      the investigation of PE, especially in regards of iodine uptake in pulmonary vasculature and&#xD;
      lung parenchyma. Postprocessing techniques improve visualisation of low concentrations of&#xD;
      iodine contrast media.This has shown potential in reducing the amount of contrast media,&#xD;
      salvaging scans with suboptimal contrast enhancement and for improving visualisation of&#xD;
      incidental pulmonary embolisms in portal venous chest CT scans. Other significant DE&#xD;
      postprocessing techniques include the substraction of iodine, creating virtual non-contrast&#xD;
      images in addition to the dual energy. This technique has proven useful in evaluation of&#xD;
      different thoracic and abdominal parenchymal lesions.&#xD;
&#xD;
      Objective: To evaluate sensitivity of chest DECT in portal venous phase in the diagnosis of&#xD;
      PE compared to standard care DE CTPA. Furthermore, the prevalence and management of&#xD;
      incidental findings will be evaluated.&#xD;
&#xD;
      Design: Patients enrolled in this study will undergo a venous phase chest DE CT in addition&#xD;
      to standard care DE CTPA. The two scans will be performed consecutively using the same&#xD;
      contrast media bolus. Standard DE reconstructions of all scans will be obtained for&#xD;
      radiological evaluation and reporting in regards of suspected PE.&#xD;
&#xD;
      Both scans with standard DE reconstructions will be available for clinical evaluation and&#xD;
      patient care in the standard care AGFA PACS system. Radiological reading and reporting will&#xD;
      be performed as usual in the clinical setting.&#xD;
&#xD;
      For research purposes, additional post-processing procedures may be performed by the readers&#xD;
      in Philips IntelliSpace Portal or Siemens Syngo.via depending on the scanner applied. The&#xD;
      standard CTPA will be interpreted by a thoracic radiologist and used as reference. The&#xD;
      corresponding portal venous chest CT will be interpreted individually by two other certified&#xD;
      radiologists in order to avoid recall bias. In case of disagreement in the venous chest CT,&#xD;
      an independent radiologist not elsewhere involved will be consulted. If a PE detected on the&#xD;
      portal venous scan is not detected on the reference CTPA, the reference reader will&#xD;
      re-evaluate the CTPA.&#xD;
&#xD;
      Patient characteristics, clinical information, radiation dose, contrast media, clinical&#xD;
      diagnosis, incidental findings and recommendations of further clinical management according&#xD;
      to clinical guidelines will be recorded in a secure web-based database.&#xD;
&#xD;
      Study population: Patients aged â‰¥50 with suspected pulmonary embolism who are having&#xD;
      performed a standard care CTPA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity</measure>
    <time_frame>through study completion, approx. of 1 year</time_frame>
    <description>Per patient sensitivity of portal venous phase chest DECT in diagnosing PE compared to the corresponding reference CTPA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity</measure>
    <time_frame>through study completion, approx. 1 year</time_frame>
    <description>Per patient specificity of portal venous phase chest DECT in diagnosing PE compared to the corresponding reference CTPA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity</measure>
    <time_frame>through study completion, approx. of 1 year</time_frame>
    <description>Lobe and segment based sensitivity of portal venous phase chest DECT in diagnosing PE compared to the corresponding reference CTPA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity</measure>
    <time_frame>through study completion, approx. of 1 year</time_frame>
    <description>Lobe and segment based specificicty of portal venous phase chest DECT in diagnosing PE compared to the corresponding reference CTPA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidental findings</measure>
    <time_frame>through study completion, approx. of 1 year</time_frame>
    <description>Evaluation and management of incidental findings in portal venous phase chest CT compared to standard care CTPA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iodine mapping</measure>
    <time_frame>through study completion, approx. of 1 year</time_frame>
    <description>Comparison of perfusion defects on iodine mapping between portal venous chest CT and CTPA. Descriptive.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Pulmonary Embolus/Emboli</condition>
  <condition>Thromboembolism, Pulmonary</condition>
  <arm_group>
    <arm_group_label>All eligible patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients undergo the same CT protocol in addition to standard care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Dual energy / spectral portal venous chest computed tomography</intervention_name>
    <description>Each patient undergoes an additional dual energy / spectral chest CT in addition to standard care CTPA. The intervention is performed immediately after standard care CTPA.</description>
    <arm_group_label>All eligible patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients suspected for pulmonary embolism undergoing a computed tomography pulmonary&#xD;
             angiography&#xD;
&#xD;
          -  Minimum age 50 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Temporarily or permanently incompetent patient not able to give informed consent&#xD;
&#xD;
          -  No informed consent obtained for other reasons&#xD;
&#xD;
          -  Allergic to iodine based contrast media&#xD;
&#xD;
          -  Impaired renal function&#xD;
&#xD;
          -  Patients with thyreotoxicosis&#xD;
&#xD;
          -  Non-diagnostic quality of computed tomography images&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yecatarina Z Rohde, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Copenhagen University Herlev Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yecatarina Zincuk Z Rohde, MD</last_name>
    <phone>+4560222733</phone>
    <email>katjazincuk@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael B Andersen, MD</last_name>
    <phone>004531254343</phone>
    <email>michael.brun.andersen@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Copenhagen University Gentofte Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Hellerup</state>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liva J Spindler, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Copenhagen University Hospital, Herlev Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Herlev</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis L Plesner</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 20, 2021</study_first_submitted>
  <study_first_submitted_qc>April 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Copenhagen University Hospital at Herlev</investigator_affiliation>
    <investigator_full_name>Yecatarina Zincuk Rohde, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>CT</keyword>
  <keyword>CTPA</keyword>
  <keyword>Computed tomography</keyword>
  <keyword>Computed tomography pulmonary angiography</keyword>
  <keyword>Dual energy</keyword>
  <keyword>Spectral</keyword>
  <keyword>Sensitivity</keyword>
  <keyword>Incidental findings</keyword>
  <keyword>Iodine mapping</keyword>
  <keyword>Radiology</keyword>
  <keyword>Imaging</keyword>
  <keyword>Diagnostic accuracy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

